SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-034213
Filing Date
2013-06-11
Accepted
2013-06-11 17:07:59
Documents
1
Period of Report
2013-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd382927.html 4  
1 FORM 4 rrd382927.xml 4 3770
  Complete submission text file 0001181431-13-034213.txt   5188
Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Bitterman Robert J (Reporting) CIK: 0001304395 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54910 | Film No.: 13906702

Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations